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Background. Most mortality studies of psychiatric patients published to date have been conducted in hospital-based
systems of care. This paper describes a study of the causes of death and associated risk factors among psychiatric
patients who were followed up over a 20-year period in an area where psychiatric care is entirely provided by
community-based psychiatric services.
Method. All subjects in contact with the South Verona Community-based Mental Health Service (CMHS) over a
20-year period with an ICD-10 psychiatric diagnosis were included. Of these 6956 patients, 938 died during the study
period. Standardized mortality ratios (SMRs) and Poisson multiple regressions were used to assess the excess of
mortality in the sample compared with the general population.
Results. The overall SMR of the psychiatric patients was 1.88. Mortality was significantly high among out-patients
[SMR 1.71, 95% confidence interval (CI) 1.6–1.8], and higher still following the first admission (SMR 2.61, 95%
CI 2.4–2.9). The SMR for infectious diseases was higher among younger patients and extremely high in patients with
diagnoses of drug addiction (216.40, 95% CI 142.5–328.6) and personality disorders (20.87, 95% CI 5.2–83.4).
Conclusions. This study found that psychiatric patients in contact with a CMHS have an almost twofold higher
mortality rate than the general population. These findings demonstrate that, since the closure of long-stay psychiatric
hospitals, the physical health care of people with mental health problems is often neglected and clearly requires
greater attention by health-care policymakers, services and professionals.
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Introduction
Research on the causes of death of psychiatric patients
is a worthwhile endeavour as it has long been rec-
ognized that death rates among patients with chronic
mental illnesses are higher than among the general
population (Farr, 1841 ; Malzberg, 1934 ; Babigian &
Odoroff, 1969 ; Harris & Barraclough, 1998 ; Sims, 2001 ;
Goff et al. 2005).
In a meta-analysis of 152 reports about the mor-
tality of patients with mental disorders, Harris &
Barraclough (1998) found that, although people with
mental disorders have an increased risk of premature
death, the highest risks from both natural and un-
natural causes are from substance abuse and eating
disorders. They also found that the risk of death from
unnatural causes is especially high among people with
schizophrenia and major depression whereas the risk
of death from natural causes is markedly increased for
organic mental disorders, mental retardation and epi-
lepsy.
Regarding organic mental disorders, some studies
have identified a high association between mortality
and antipsychotic drugs in patients with dementia,
although it is not clear whether this is due to a direct
medication effect or to the pathophysiology under-
lying neuropsychiatric symptoms that prompt anti-
psychotic use (Schneider et al. 2005 ; Wang et al. 2005 ;
Kales et al. 2007).
Most previous mortality studies have been conduc-
ted in areas where hospital-based systems of mental
care are the norm. For example, a study by Craig & Lin
(1981) suggested that, in the USA, deinstitutionaliza-
tion, through a variety of mechanisms, may have had a
beneficial effect on the mortality of elderly patients
who remain hospitalized. Other studies have shown a
decrease in the excess mortality of psychiatric patients
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after a reduction in the provision of long-stay psychi-
atric hospital care (Tsuang & Simpson, 1985 ; Allebeck
& Wistedt, 1986 ; Casadebaig & Quemada, 1991). De-
institutionalization, however, also seems to be as-
sociated with increased rates in deaths for causes
considered ‘behaviourally avoidable ’ (i.e. preventable
with adequate health promotion policies), such as
cardiovascular and unnatural causes for both genders
(Hansen et al. 2001) and for suicide (Mortensen & Juel,
1993 ; Martiello et al. 2006).
Vreeland (2007) stated that the problem of increased
morbidity and premature death in people with serious
mental illness needed to be addressed with a trans-
formation of the current mental health system and
the integration of physical and mental health care,
towards a system that uses a coordinated, multi-
disciplinary holistic approach. This should overcome
some of the multiple barriers that make it difficult for
individuals with serious mental illness to access qual-
ity health care.
Research and intervention studies for improving
medical care for people with serious mental illness
have spanned a continuum of interprofessional
involvement, ranging from staff and patient train-
ing to on-site consultation by medical staff, multi-
disciplinary collaborative care approaches, and
facilitated linkages between community and mental
health and medical providers. Researchers suggest
that it is important to develop and coordinate medical
care in a community medical setting (Leucht &
Fountoulakis, 2006 ; Druss & Newcomer, 2007). In
addition, great attention should be paid to those
patients who develop psychiatric symptoms as co-
morbidity of cardiovascular accident and stroke (Politi
et al. 2006). This would contribute to diminish the
mortality of people with a secondary psychiatric diag-
nosis.
However, there is still a need to explore mortality in
different service settings, such as community services,
because mortality is a useful indicator of the quality of
a health-care system over time.
The aim of this paper was to study mortality, causes
of death and associated risk factors among psychiatric
patients followed up over a 20-year period in an
area where psychiatric care is entirely provided by
community-based psychiatric services and has been
monitored by a case register since 1978 (Tansella et al.
2006). This research allowed us to repeat the mortality
analyses published in a previous study by Amaddeo
et al. (1995) conducted in South Verona for a time
period of 10 years, on a sample followed up for a
twofold longer period, also adding a detailed analysis
of causes of death that was not possible to perform




Data were drawn from the area of South Verona that
includes part of Verona (a city of about 260 000 in-
habitants in the Veneto region in northeast Italy) and
two neighbouring small towns (Castel d’Azzano and
Buttapietra). South Verona is a mainly urban area with
a predominance of service and manufacturing indus-
tries. The total population is about 75 000 (population
density 1073/km2). The main agency providing psy-
chiatric care for the adult population of this area is
the South Verona Community-based Mental Health
Service (CMHS), run by the Section of Psychiatry and
Clinical Psychology of the University of Verona. This
service provides a wide range of well-integrated hos-
pital and community services, including a 15-bed in-
patient acute ward at the University General Hospital,
a Community Mental Health Centre (CMHC) that
provides day care and rehabilitation, an out-patient
department, scheduled domiciliary visits, an accident
and emergency department, a 24-hour staffed hostel
and sheltered apartments.
According to the Italian psychiatric reform, in-
patient care can only be provided in general hospital
psychiatric wards or private psychiatric clinics. The
Italian National Health Service (NHS) provides medi-
cal and psychiatric care, including admissions to some
private clinics, free of charge. Further information on
the research setting can be found elsewhere (Tansella
et al. 1998).
The Psychiatric Case Register (PCR)
The South Verona Psychiatric Case Register (PCR) was
started on 31 December 1978 and has been operating
ever since (Tansella et al. 1998). The PCR collects the
following information : at first contact with a psychi-
atric service, sociodemographic information, past psy-
chiatric and medical history, and clinical data for each
resident of South Verona aged o14 years. Diagnoses
are made by a clinician according to ICD-10 and then
coded into 12 standard diagnostic groups. The diag-
noses of all new cases are routinely reviewed by the
case-register administrator. All psychiatric services of
South Verona and the larger province of Verona pro-
vide data to the PCR for South Verona residents. All
contacts with the psychiatric staff (nurses, psychi-
atrists, psychologists, social workers, etc.) are re-
corded.
Study design and statistical analysis
The study design was approved by the Verona local
research ethics committee of the University Hospital
of Verona, Italy (Appr. Prot. No. 1098).
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All subjects who had at least one contact with the
South Verona CMHS during a 20-year period (from
1 January 1982 to 31 December 2001) and who at the
first contact or later received an ICD-10 (ICD-9 until
1992, then converted to ICD-10 using World Health
Organization conversion tables) psychiatric diagnosis
were included in this study. Data were censored either
on death date or date of emigration from the study
area (19% of patients) or on 31 December 2001, which-
ever came first. Person-years were calculated for each
patient. Four age groups were considered: 14–24,
25–44, 45–64, and o65 years. For the purposes of
the present study, ICD diagnoses were collapsed into
seven diagnostic groups : schizophrenia and related
disorders (ICD-10 codes F20–F29, F84), affective dis-
orders (ICD-10 codes F30–F33, F34.1, F34.8, F34.9,
F38.00, F38.10, F38.8, F39, F41.2, F43.20–F43.22), neu-
rotic, stress-related and somatoform disorders (F40,
F41.0, F41.1, F41.3, F41.8, F41.9, F42, F44, F45, F48, F54),
disorders of personality and behaviour of the adult
(F34.0, F52, F60–F69), drug addiction (F11–F19.1, F19.2,
F19.3, F55), alcohol addiction (F10.1–F10.3), and other
diagnoses (including organic psychoses, eating dis-
orders, mental retardation, dementia).
According to type of care received, person-years
were classified as in-patient or out-patient. In-patient
person-years refer to those that followed first ad-
mission to hospital. Out-patient person-years refer to
the period preceding hospital admission and person-
years of patients who had never been admitted to
hospital.
Five time-intervals from registration in the PCR
were considered : (1) first year after registration, (2) 1–2
years after registration, (3) 2–5 years after registration,
(4) 5–10 years after registration and (5)>10 years after
registration.
Mortality and cause of death were ascertained using
different procedures and sources. Information about
whether the patients were alive was provided by
linkage to the Central Person Registry of the Munici-
palities of Verona, Castel d’Azzano and Buttapietra.
For those not alive, causes of death were established
through linkage to the database of the Local Health
District of Verona. Consultation of the Registries
of Deaths of the Municipalities of Verona, Castel
d’Azzano and Buttapietra and of the Service of For-
ensic Medicine of the University of Verona provided
missing information. The cause of death was estab-
lished in 90% of cases. These agencies were also able
to provide vital status and causes of death for people
still registered in area of the municipality who had
died outside the study area.
The causes of death were categorized as follows: (1)
infectious diseases (including infectious complications
of AIDS), (2) malignant neoplasms, (3) endocrine
diseases, (4) blood diseases, (5) organic mental dis-
orders, (6) nervous system diseases, (7) circulatory
system diseases (including cardiovascular and
cerebrovascular disorders), (8) respiratory system
diseases, (9) digestive system diseases, (10) genital-
urinary system diseases, (11) osteoarticular system
diseases, (12) congenital disease, (13) diseases ill-
defined and (14) traumatic episodes. All causes of
death were defined according to ICD-9-CM classifi-
cation (National Center for Health Statistics, 2006).
Standardized mortality ratios (SMRs) were used
to assess the risk of premature mortality in the pre-
viously described groups. The SMR compares the ob-
served number of deaths with the expected number
for each cause. Person-years were calculated for
each patient and were divided into five 4-year periods.
The expected number of deaths was obtained by ap-
plying to the corresponding sex and age structure
(person-years), for each of the five 4-year periods con-
sidered, the age- gender-, cause- and period-specific
mortality rates of the general population in the Veneto
region. These specific mortality rates were obtained
from the Italian National Institute of Health.
Poisson regression analyses have been used
previously to study the association between patient
characteristics and mortality (Consul, 1989). In the
current study, a multiple Poisson regression analysis
was performed to analyse the combined effect of
independent variables (gender, age, diagnoses and
interval from registration) on mortality. To simplify
the interpretation of the Poisson regression models,
we present the coefficients in terms of mortality rate
ratios (RRs) and their 95% confidence intervals (CIs).
The estimated RR is equal to the log of the quotient
between the expected number of events for each value
of the predictor variable and the value used as re-
ferent, with the other variables held constant in the
model. For example, a mortality RR <1 means that
the expected number of deaths is lower for this par-
ticular value of the variables compared with the value
used as referent (protective effect) ; and patients
with a mortality RR >1 have an increased mortality
rate.
Results
In this study, 6956 patients (3135 males and 3821
females) for a total of 59 139 person-years (26 922
males and 32 217 females) were included. About 8% of
the patients had a diagnosis of schizophrenia, 29%
affective disorders, 14% drug or alcohol addiction,
22% neurotic and somatoform disorders, 6% person-
ality disorders and 21% other diagnoses. Of the whole
sample, 938 (527 males and 411 females) died during
the study period.
Mortality and cause of death among psychiatric patients 1877
The total SMR of our psychiatric population was
1.88 (95% CI 1.8–2.0), representing an increase of 88%
in mortality compared with the general population.
The SMR was slightly higher among males than fe-
males (2.11, 95% CI 1.9–2.3, v. 1.65, 95% CI 1.5–1.8).
The data presented in Table 1 reveal that the younger
the patient, the higher the SMR. This inverse corre-
lation seems to be more evident among females than
males ; female SMRs decrease from 8.81 (95% CI 4.6–
16.9) in younger patients to 1.40 (95% CI 1.2–1.6) in the
older patients, whereas in males SMRs vary from only
4.26 (95% CI 2.7–6.8) to 1.49 (95% CI 1.3–1.7) and the
highest excess in mortality rate is attributable to the
young-adult group (age 25–44 years, SMR 6.93, 95% CI
5.8–8.3).
Mortality was significantly high for out-patients
(SMR 1.70, 95% CI 1.6–1.8) and, as expected, it was
higher after the first admission (SMR 2.61, 95% CI
2.4–2.9).
Time interval since registration had a negative cor-
relation with the SMR, which was higher during the
first year after registration (SMR 3.44, 95% CI 3.0–4.0),
remained fairly high between the first and the second
year after registration (SMR 2.61, 95% CI 2.2–3.1), and
then decreased to 1.80 after 2 years, 1.52 after 5 years,
and 1.40 after 10 years.
All psychiatric diagnoses showed a significant ex-
cess mortality (p<0.01). The diagnostic group with the
highest SMR for all causes (Table 1) was drug addic-
tion (SMR 6.19, 95% CI 4.9–7.7), followed by alcohol-
ism (SMR 3.16, 95% CI 2.6–3.9) and personality
disorders (SMR 2.74, 95% CI 2.0–3.7).
With regard to the single causes of death, our data
reveal 27 observed death for infectious diseases, out of
Table 1. Mortality in psychiatric patients by patient characteristics and time interval from registration
PY O E SMR 95% CI p
All patients (age group, years) 59 139 938 499.33 1.88 1.8–2.0 **
14–24 7334 27 5.25 5.15 3.5–7.5 **
25–44 23 755 154 24.51 6.28 5.4–7.4 **
45–64 18 775 236 107.49 2.19 1.9–2.5 **
o65 9275 521 362.08 1.44 1.3–1.6 **
Males (age group, years) 26 922 527 249.66 2.11 1.9–2.3 **
14–24 4121 18 4.22 4.26 2.7–6.8 **
25–44 12 356 118 17.01 6.93 5.8–8.3 **
45–64 7509 149 65.95 2.26 1.9–2.6 **
o65 2936 242 162.48 1.49 1.3–1.7 **
Females (age group, years) 32 217 411 249.67 1.65 1.5–1.8 **
14–24 3213 9 1.02 8.81 4.6–16.9 **
25–44 11 399 36 7.50 4.80 3.5–6.7 **
45–64 11 266 87 41.55 2.09 1.7–2.6 **
o65 6339 279 199.61 1.40 1.2–1.6 **
In-patients 15 007 368 140.97 2.61 2.4–2.9 **
Out-patients 44 153 613 358.38 1.71 1.6–1.8 **
Diagnosis
Schizophrenia 4613 69 32.13 2.15 1.7–2.7 **
Affective disorders 17 180 293 189.14 1.55 1.4–1.7 **
Neurosis and somatoform disorders 12 956 114 96.83 1.18 0.9–1.4
Personality disorders 3627 41 14.95 2.74 2.0–3.7 **
Drug addiction 5266 77 12.45 6.19 4.9–7.7 **
Alcoholism 2986 93 29.47 3.16 2.6–3.9 **
Other diagnoses 12 511 251 124.37 2.02 1.8–2.3 **
Interval from registration (years)
f1 6710 193 56.09 3.44 3.0–4.0 **
1–2 6086 126 48.21 2.61 2.2–3.1 **
2–5 15 338 214 118.40 1.81 1.6–2.1 **
5–10 17 144 209 137.33 1.52 1.3–1.7 **
>10 13 861 196 139.31 1.41 1.2–1.6 **
PY, Person-years ; O, observed death ; E, expected death ; SMR, standardized mortality ratio ; CI, confidence interval.
** p<0.01.
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2.65 expected, with an SMR of 10.18 (95% CI 6.9–14.8,
p<0.01), the highest after the ‘ ill-defined’ cause of
death group (Table 2). Males seem to be at a higher
risk of infectious diseases with an SMR of 17 (95% CI
11.2–26) compared with 3.66 (95% CI 1.5–8.8) among
females.
SMRs for infectious diseases are higher among
younger patients, as death from such causes are very
rare at a young age in the general population (low
expected deaths). Mortality for endocrine disease was
significantly high only in the 25–44 years age group
(Table 3).
Mortality for all causes became similar to that of
the general population in patients older than 65 years
except for causes related to respiratory, osteoarticular,
congenital diseases, traumatic and ill-defined causes.
Table 4 shows the effect of psychiatric diagnoses on
each cause of death. SMRs for infectious diseases are
extremely high in patients with drug addiction (SMR
216.40, 95% CI 142.5–328.6) and personality disorders
(SMR 20.87, 95% CI 5.2–83.4) ; those for blood diseases
and the genital-urinary system are significant only in
patients with schizophrenia ; and for ill-defined causes
of death and for traumatic episodes, SMRs are signifi-
cant in all psychiatric diagnoses. The risk of dying
from neoplasm is higher when compared with the
general population, but only for patients diagnosed
with alcoholism.
Poisson regression results
Gender, age, diagnosis and interval from registration
were all significantly associated with mortality in a
univariate Poisson regression analysis. For all causes
of death, the likelihood ratio test result was 42.76
(p<0.001) for gender, 925.67 (p<0.001) for age, 103.27
(p<0.001) for diagnosis, and 87.01 (p<0.001) for in-
terval from registration. Similar results were obtained
when analysing separately in-patients, out-patients
and mortality for neoplasms, cardiovascular diseases,
infectious diseases and traumatic episodes, but not
for age, which was shown to be not significantly as-
sociated with mortality for traumatic episodes.
The combined effect of these variables on mortality,
for all causes of death and separately for neoplasms,
cardiovascular diseases, infectious diseases and trau-
matic episodes, was obtained from a multiple Poisson
regression analysis (Table 5). Gender and age were
always significantly associated with mortality, females
had a lower RR in all groups, an RR that significantly
increased for every 5 years of age, except for infectious
diseases. Drug addiction was significantly associated
with mortality for traumatic episodes (RR 0.48, 95% CI
0.26–0.89) and not associated with all causes, neo-
plasms infectious and cardiovascular diseases ; al-
coholism was significantly associated with mortality
for all causes (RR 1.44, 95% CI 1.05–1.97) and for neo-
plasms (RR 2.51, 95% CI 1.27–4.97). The interval from
registration showed a significant association with mor-
tality in the four groups, except infectious diseases.
Discussion
Compared to the previous mortality study by
Amaddeo et al. (1995), the current study followed up
Table 2. Mortality by causes of death and gender
Male (PY 26922) Female (PY 32217) Total (PY 59139)
O E SMR 95% CI O E SMR 95% CI O E SMR 95% CI
Infectious disease 22 1.29 17.09** 11.2–26.0 5 1.36 3.66** 1.5–8.8 27 2.65 10.18** 6.9–14.8
Neoplasm 113 88.54 1.28** 1.1–1.5 92 75.99 1.21 0.9–1.5 205 164.53 1.25** 1.1–1.4
Endocrine disease 5 4.22 1.18 0.5–2.8 10 8.02 1.25 0.7–2.3 15 12.24 1.22 0.7–2.0
Blood disease 2 0.56 3.56 0.9–14.2 2 0.64 3.11 0.8–12.4 4 1.20 3.32* 1.2–8.8
Organic mental disorder 8 2.48 3.22** 1.6–6.4 7 4.20 1.67 0.8–3.5 15 6.68 2.24** 1.3–3.7
Nervous system 8 4.18 1.91 0.9–3.8 12 5.87 2.04* 1.2–3.6 20 10.05 1.99** 1.3–3.1
Circulatory system 113 88.06 1.28** 1.1–1.5 114 106.84 1.07 0.9–1.3 227 194.90 1.65* 1.0–1.3
Respiratory system 39 15.73 2.48** 1.8–3.4 24 12.92 1.86** 1.2–2.8 63 28.65 2.20** 1.7–2.8
Digestive system 35 14.75 2.37** 1.7–3.3 23 13.73 1.68* 1.1–2.5 58 28.48 2.04** 1.6–2.6
Genital-urinary system 9 2.84 3.16** 1.6–6.1 6 3.01 1.99 0.9–4.4 15 5.85 2.56** 1.5–4.2
Osteoarticular system 4 0.55 7.30** 2.7–19.5 2 1.37 1.46 0.4–5.8 6 1.91 3.13** 1.4–7.0
Congenital disease 3 0.47 6.33** 2.0–19.6 0 0.46 0.00 – 3 0.94 3.20* 1.0–9.9
Ill defined 37 2.50 14.79** 10.7–20.4 34 3.24 10.48** 7.5–14.7 71 5.75 12.36** 9.8–15.6
Traumatic episodes 90 20.42 4.41** 3.6–5.4 48 10.61 4.52** 3.4–6.0 138 31.03 4.45** 3.8–5.2
PY, Person-years ; O, observed death ; E, expected death ; SMR, standardized mortality ratio ; CI, confidence interval.
* p<0.05, ** p<0.01.
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Table 3. Mortality by causes of death and age group
14–24 years (PY 7334) 25–44 years (PY 23755) 45–64 years (PY 18775) >65 years (PY 9275)
O E SMR 95% CI O E SMR 95% CI O E SMR 95% CI O E SMR 95% CI
Infectious disease 1 0.05 18.95** 2.7–134.5 23 0.32 72.26** 48.0–108.7 1 0.59 1.69 0.2–12.0 2 1.69 1.18 0.3–4.7
Neoplasm 1 0.44 0.28 0.3–16.2 13 6.51 2.00* 1.1–3.4 73 54.52 1.34* 1.1–1.7 118 103.06 1.14 0.9–1.4
Endocrine disease 0 0.04 0.00 2 0.24 8.38** 2.1–33.5 3 1.74 1.72 0.5–5.3 10 10.23 0.98 0.5–1.8
Blood disease 0 0.07 0.00 2 0.15 13.15** 3.3–52.6 1 0.17 6.02 0.8–42.7 1 0.81 1.23 0.2–8.7
Organic mental disorder 0 0.02 0.00 2 0.30 6.61** 1.6–26.4 3 0.60 4.96** 1.6–15.4 10 5.76 1.74 0.9–3.2
Nervous system 0 0.14 0.00 1 0.49 2.06 0.3–14.6 6 1.81 3.32** 1.5–7.4 13 7.63 1.70 0.9–2.9
Circulatory system 0 0.31 0.00 11 3.27 3.36** 1.9–6.1 43 26.27 1.64** 1.2–2.2 173 165.05 1.05 0.9–1.2
Respiratory system 1 0.11 8.70* 1.2–61.8 2 0.48 4.14* 1.0–16.5 11 2.66 4.14** 2.3–7.5 49 25.39 1.93** 1.4–2.5
Digestive system 1 0.08 11.94* 1.7–84.7 12 1.84 6.53** 3.7–11.5 20 8.69 2.30** 1.5–3.6 25 17.87 1.40 0.9–2.1
Genital-urinary system 0 0.04 0.00 2 0.23 8.58** 2.1–34.3 4 0.81 4.91** 1.8–13.1 9 4.77 1.89 0.9–3.6
Osteoarticular system 0 0.02 0.00 0 0.09 0.00 1 0.40 2.50 0.3–17.7 5 1.40 3.56** 1.5–8.5
Congenital disease 1 0.09 11.30* 1.6–80.2 0 0.23 0.00 0 0.33 0.00 2 0.29 6.93** 1.7–28.0
Ill defined 2 0.12 16.75** 4.2–67.0 9 0.38 23.47** 12.2–45.1 26 0.78 33.31** 22.7–48.9 34 4.46 7.62** 5.4–10.7
Traumatic episodes 18 3.77 4.78** 3.0–7.6 60 8.07 7.44** 5.8–9.6 28 7.86 3.56** 2.5–5.1 32 11.33 2.82** 1.9–4.0
PY, Person-years ; O, observed death ; E, expected death ; SMR, standardized mortality ratio ; CI, confidence interval.
* p<0.05, ** p<0.01.















SMR 95% CI SMR 95% CI SMR 95% CI SMR 95% CI SMR 95% CI SMR 95% CI SMR 95% CI
Infectious disease 5.53 0.8–39.2 1.01 0.1–7.1 0.00 20.87** 5.2–83.4 216.40** 142.5–328.6 0.00 1.64 5.2–83.4
Neoplasm 1.07 0.6–1.9 1.22 0.9–1.5 0.94 0.6–1.3 1.26 0.6–2.6 0.49 0.1–3.5 2.28** 1.6–3.3 1.28 0.9–1.7
Endocrine disease 0.00 1.23 0.5–2.7 0.40 0.1–2.8 0.00 0.00 0.00 2.57** 1.3–5.1
Blood disease 12.85* 1.8–91.2 0.00 0.00 0.00 0.00 0.00 9.3** 3.0–28.9
Organic mental disorder 0.00 0.78 0.2–3.1 0.00 0.00 0.00 13.32** 4.3–41.3 5.26** 2.8–9.8
Nervous system 1.52 0.2–10.8 2.28* 1.2–4.4 0.51 0.1–3.6 3.52 0.5–25.0 0.00 4.11* 1.0–16.4 2.4* 1.1–5.3
Circulatory system 1.27 0.8–2.1 1.01 0.8–1.3 0.95 0.7–1.3 1.54 0.7–3.2 0.49 0.1–1.9 2.07** 1.3–3.2 1.36** 1.1–1.7
Respiratory system 0.64 0.1–4.5 1.62* 1.0–2.6 1.50 0.7–3.0 6.05** 2.3–16.1 1.11 0.1–7.9 3.83** 1.6–9.2 3.21** 2.2–4.7
Digestive system 3.04** 1.4–6.8 1.29 0.8–2.2 1.41 0.7–2.8 3.17* 1.0–9.8 9.57** 3.9–23.0 5.68** 3.2–10.0 1.6 0.8–2.9
Genital-urinary system 8.65** 2.8–26.8 2.76* 1.2–6.1 0.00 0.00 5.22 0.7–37.0 0.00 3.14* 1.3–7.5
Osteoarticular system 0.00 5.21** 1.9–13.9 2.52 0.3–17.9 0.00 0.00 0.00 2.16 0.3–15.3
Congenital disease 0.00 3.33 0.5–23.6 0.00 0.00 0.00 0.00 10.1** 2.5–40.4
Ill defined 24.21** 12.1–48.4 11.48** 7.5–17.6 6.73** 3.4–13.5 14.44** 3.6–57.7 18.76** 7.8–45.1 41.48** 21.6–79.7 10.14** 6.4–16.1
Traumatic episodes 7.91** 4.9–12.5 4.03** 2.9–5.6 1.5 0.8–2.9 6.40** 3.5–11.5 11.03** 7.8–15.5 3.62** 1.7–7.6 3.32** 2.2–4.9
PY, Person-years ; SMR, standardized mortality ratio ; CI, confidence interval.








Table 5. Rate ratios for all causes of death, neoplasms and cardiovascular disease (Poisson multiple regression analyses)
All causes Neoplasms Cardiovascular diseases Infectious disease Traumatic episodes
RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI
Gender
Male 1 Referent 1 Referent 1 Referent 1 Referent 1 Referent
Female 0.53 0.47–0.61 0.48 0.36–0.65 0.54 0.41–0.71 0.75 0.26–2.12 0.53 0.36–0.77
Age
Every 5 years 1.07 1.06–1.07 1.07 1.06–1.08 1.10 1.09–1.11 1.03 1.00–1.06 1.02 1.01–1.03
Diagnosis
Schizophrenia 1 Referent 1 Referent 1 Referent 1 Referent 1 Referent
Affective disorders 0.75 0.58–0.98 1.16 0.63–2.13 0.80 0.46–1.40 0.23 0.01–3.77 0.48 0.27–0.85
Neurosis and somatoform disorders 0.59 0.44–0.80 0.89 0.45–1.73 0.82 0.45–1.49 3.87 0–0 0.19 0.08–0.42
Personality disorders 1.04 0.71–1.54 1.05 0.41–2.66 0.99 0.40–2.43 2.92 0.26–32.73 0.79 0.37–1.67
Drug addiction 1.09 0.83–1.42 1.07 0.56–2.04 1.22 0.70–2.15 0.39 0.02–6.32 0.48 0.26–0.89
Alcoholism 1.44 1.05–1.97 2.51 1.27–4.97 1.46 0.73–2.91 2.94 0–0 0.46 0.19–1.11
Other diagnoses 2.80 1.99–3.93 0.22 0.03–1.74 0.45 0.10–1.99 28.25 3.35–238.52 1.79 0.97–3.31
Interval from registration (years)
f1 1 Referent 1 Referent 1 Referent 1 Referent 1 Referent
1–2 0.75 0.60–0.94 0.71 0.43–1.18 0.95 0.61–1.49 0.70 0.12–4.21 1.05 0.60–1.85
2–5 0.51 0.42–0.62 0.61 0.41–0.92 0.44 0.28–0.68 0.25 0.04–1.49 0.58 0.35–0.97
5–10 0.40 0.33–0.49 0.40 0.26–0.62 0.45 0.30–0.68 1.08 0.30–3.87 0.44 0.26–0.74
>10 0.36 0.29–0.44 0.39 0.26–0.61 0.54 0.36–0.80 0.69 0.17–2.72 0.37 0.21–0.66
















psychiatric patients over a 20-year period, allowing for
a more detailed exploration of the causes of death ; the
results of the earlier study have been widely con-
firmed.
Our data show that psychiatric patients have an al-
most twofold higher mortality rate than the general
population. This value is lower than that of previous
studies. For example, a meta-analysis conducted by
Harris & Barraclough (1998) revealed an SMR ranging
from 0.96 to 20.73. Other studies confirm that there is a
decrease in mortality on moving from hospital-based
to community-based psychiatric care (Casadebaig &
Quemada, 1991; Sohlman & Lehtinen, 1999), and this
could be the reason for the lower SMR in our popu-
lation, which was served by a community-based sys-
tem of care.
The majority of studies investigating mortality
among psychiatric patients analysed cohorts of long-
stay in-patients (Licht et al. 1993 ; Rasanen et al. 2002)
or patients who had had at least one admission to a
psychiatric ward (Haugland et al. 1983 ; Allebeck &
Wistedt, 1986 ; Zilber et al. 1989 ; Mortensen & Juel,
1993), even if studies were conducted in dein-
stitutionalized service systems (Hansen et al. 2001). A
recent Italian study (Meloni et al. 2006) found an SMR
of 3.0 in a cohort of psychiatric in-patients in Florence
followed up for 16 years after hospital discharge. Few
studies have calculate the SMR of both in-patients and
out-patients. Of note, one of these studies (Hassall
et al. 1988) found an SMR of 1.8, very similar to the
SMR of 1.88 of our population, with a clear difference
between in-patients (2.2) and out-patients (1.4), a dif-
ference that is also confirmed in our sample (2.6 v. 1.7).
Harris & Barraclough (1998) report a similar difference
between patients treated in community-based systems
of care (1.98) compared to patients admitted to hospi-
tals (2.79). This may be due to the more severe physical
and/or psychiatric status of patients after their ad-
mission to hospital.
Our study demonstrated that both male and female
psychiatric patients are at a higher risk of premature
death, but males have an overall SMR that is more
than twofold higher than the general population,
whereas females have a mortality rate that is about
65% higher than the general population. Similar re-
sults are presented by Politi et al. (2002) and Kisely
et al. (2005). Even though, for the both genders, the
SMR is statistically significant in each age group,
younger females (aged 14–24 years) having the highest
SMR. This is probably referable to the high incidence
of drug addiction and alcoholism diagnosis found
in this group. Women with a diagnosis of alcohol ad-
diction were also reported to have a higher mortality
risk in the meta-analysis of Harris & Barraclough
(1998).
Other studies confirm the higher risk of death for
younger patients and for patients with substance
abuse (Malzberg, 1934 ; Babigian & Odoroff, 1969 ;
Zilber et al. 1989 ; Amaddeo et al. 1995 ; Harris &
Barraclough, 1998 ; Rosen et al. 2008). Our finding
of high SMRs for infectious diseases among younger
patients (18.95 for the 14–24 years age group and 72.26
for the 25–44 years age group) is probably due to the
fact that deaths from these causes are very rare at a
young age in the general population (low expected
deaths). As regards SMR for specific causes of death,
in an Italian study conducted in Florence among dis-
charged patients, the SMR for violent cause was 13.0,
much higher than our value of 4.45 (Meloni et al. 2006).
A strong association between drug addiction and
infectious diseases was found (SMR 216.40, 95% CI
142.5–328.6), and this could be related to the fact that,
among patients with drug addiction, there is a high
prevalence of organic diseases and infectious diseases
that are highly contagious, such as hepatitis or HIV
(Carra et al. 2008). High values of SMRs for infectious
diseases were observed in the whole cohort (10.18),
and this suggests that deinstitutionalization has not
adequately improved the detection and treatment of
physical diseases, which should be avoidable with
access to a well-resourced health-care system or ap-
propriate health policies (Amaddeo et al. 2007).
The diagnosis of alcohol addiction showed an SMR
of 3.16, but the higher risk is especially related to
particular causes of death, such as organic mental
disorder (SMR 13.32, 95% CI 4.3–41.3), digestive sys-
tem disease (SMR 5.68, 95% CI 3.2–10.0), nervous
system disease (SMR 4.11, 95% CI 1.0–16.4) and res-
piratory system diseases (SMR 3.83, 95% CI 1.6–9.2).
This result concurs with the meta-analysis of Harris
& Barraclough (1998), where the highest correlations
with alcoholism are for organic mental disorder (SMR
13.69), cirrhosis (SMR 8.86) and digestive system dis-
ease.
The association between alcoholism and damage to
the central and peripheral nervous system is well
known and the consequent alterations in the func-
tioning of the nervous system could be responsible for
the greater number of traumatic episodes, which in
our population have an SMR of 3.62 (95% CI 1.7–7.6),
similar to the findings of Harris & Barraclough (1998)
with an SMR of 3.89.
Regarding the mortality risk for neoplasm, there
was no difference found between schizophrenic
patients and the general population (SMR 1.07, 95%
CI 0.6–1.9) ; our data confirm the findings of Goldacre
et al. (2005), that there is no evidence that schizo-
phrenia provides protection against cancer.
Regression analyses confirmed other findings that
women have a lower mortality rate, that there is an
1882 L. Grigoletti et al.
increase in mortality for every 5 years of age, and that
the diagnoses have different associations with various
causes of death. The negative trend in relationship
between the mortality rate and the time interval since
registration, found in our previous study (Amaddeo
et al. 1995), was confirmed and the time extension of
our study to 20 years hasmade the results more robust.
In this study we found an SMR for psychiatric
patients lower than the rate found in other studies.
It could be the case that a community-based service is
conducive to reducing mortality. However, it is also
clear that a psychiatric disorder acts as a chronic dis-
ease in influencing a patient’s life expectancy.
The strengths of this study are the reliability of the
SMR as a good andwidely used indicator for mortality
comparisons and the fact that this is, to our knowl-
edge, the largest register-based study onmortality con-
ducted in an area totally served by a CMHS.
One limitation of this study is that it was not poss-
ible to obtain information about physical activity,
smoking and drinking habits of patients with a differ-
ent diagnosis from alcoholism. These lifestyle factors
could be important measures of how such behaviours
influence mortality, especially in a community setting,
and could help in constructing hypotheses with regard
to how the implementation of health promotion and
preventive programmes, targeted to psychiatric pa-
tients, could reduce mortality.
Other possible limitations of this study are the
amount of missing data on causes of death (approxi-
mately 10% of the whole sample). The sample size was
too small to reach statistical significance in the analy-
ses of some, more rare, causes of death when the
sample was divided by diagnoses. Because of themiss-
ing data on causes of death, caution is required in the
interpretation of the SMRs, which could be under-
estimated. Nevertheless, having explored several
sources to obtain causes of death information (includ-
ing Forensic Registries), we assume that the missing
data are equally distributed between all the causes.
From our results we can conclude that it is import-
ant for mental health services to improve their ca-
pacity to manage more effectively the physical health
problems of patients, with multidisciplinary collabor-
ative care approaches, or facilitating linkages between
mental health services and medical primary care pro-
viders.
Further research, which is ongoing in our setting, is
needed to investigate the relationship between mor-
tality in psychiatric patients and neoplasms.
It could be useful to analyse the mortality of
patients treated in community-based mental health
services, where a better integration between mental
health care and primary and secondary medical care
exists, in order to confirm if this kind of integration
leads to a reduction in mortality and if a multi-
disciplinary holistic approach could reduce the risk of
premature mortality in psychiatric patients.
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